Polygenic Risk for Type 2 Diabetes in African Americans.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
12 Mar 2024
Historique:
received: 07 02 2024
accepted: 06 03 2024
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 12 3 2024
Statut: aheadofprint

Résumé

African Americans (AAs) have been underrepresented in polygenic risk score (PRS) studies. Herein, we integrated genome-wide data from multiple observational studies on type 2 diabetes (T2D), encompassing a total of 101,987 AAs, to train and optimize an AA focused T2D PRS (PRSAA), using a Bayesian polygenic modeling method (PRS-CS). We further tested the score in three independent studies with a total of 7,275 AAs. We then compared the PRSAA to other published scores. Results show that a 1 standard deviation increase in the PRSAA was associated with 40%-60% increase in the odds of T2D (OR=1.60, 95% CI 1.37-1.88; OR=1.40, 95% CI 1.16-1.70; and OR=1.45, 95% CI 1.30-1.62) across three testing cohorts. These models captured 1.0%-2.6% of the variance (R2) in T2D on the liability scale. The positive predictive values (PPV) for three calculated score thresholds (the top 2%, 5% 10%) ranged from 14% to 35%. The PRSAA, in general, performed similarly to existing T2D PRS. Larger datasets remain needed to continue to evaluate the utility of within-ancestry scores in the AA population.

Identifiants

pubmed: 38470993
pii: 154327
doi: 10.2337/db23-0232
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 by the American Diabetes Association.

Auteurs

Marguerite R Irvin (MR)

Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Tian Ge (T)

Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Center for Precision Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Amit Patki (A)

Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Vinodh Srinivasasainagendra (V)

Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Nicole D Armstrong (ND)

Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Brittney Davis (B)

Department of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Alana C Jones (AC)

Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Emma Perez (E)

Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Mass General Brigham Personalized Medicine, Boston, MA, USA.

Lauren Stalbow (L)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Matthew Lebo (M)

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Mass General Brigham Personalized Medicine, Boston, MA, USA.
Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

Eimear Kenny (E)

Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Division of Genomic Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Ruth J F Loos (RJF)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medicine, University of Copenhagen, Copenhagen, Denmark.

Maggie C Y Ng (MCY)

Vanderbilt Genetics Institute, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Jordan W Smoller (JW)

Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Center for Precision Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

James B Meigs (JB)

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.

Leslie A Lange (LA)

Department of Epidemiology University of Colorado School of Public Health Aurora CO.

Elizabeth W Karlson (EW)

Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Mass General Brigham Personalized Medicine, Boston, MA, USA.

Nita A Limdi (NA)

Department of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Hemant K Tiwari (HK)

Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Classifications MeSH